Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer
Clinical trial NCT02688608 · COMPLETED
Trial details
- NCT number
- NCT02688608
- Sponsor
- Saad A Khan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2020-10-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.